Stanley C Erck Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stanley C Erck.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stanley C Erck. Stanley C Erck is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and CEO and President in NOVAVAX INC ($NVAX) and President and CEO in NOVAVAX INC ($NVAX) and President & CEO in INTERCELL USA, INC. ($IOMI) and President and CEO in INTERCELL USA, INC. ($IOMI).
Latest Insider Trading Transactions of Stanley C Erck
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCRX, IOMI, NVAX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 0.00 | 20,900 | 0 | 20,900 | |
| Dec 16 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 129.70 | 41,700 | 5,408,490 | 41,700 | |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | M | 5.95 | 25,000 | 148,750 | 75,000 | |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | M | 5.95 | 25,000 | 148,750 | 75,000 | |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 109.25 | 1,000 | 109,251 | 32,727 | 33.7 K to 32.7 K (-2.96 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 108.40 | 1,112 | 120,544 | 33,727 | 34.8 K to 33.7 K (-3.19 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 107.25 | 1,000 | 107,248 | 34,839 | 35.8 K to 34.8 K (-2.79 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 106.22 | 1,000 | 106,224 | 35,839 | 36.8 K to 35.8 K (-2.71 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 117.07 | 551 | 64,503 | 36,839 | 37.4 K to 36.8 K (-1.47 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 116.08 | 951 | 110,389 | 37,390 | 38.3 K to 37.4 K (-2.48 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 115.23 | 1,003 | 115,577 | 38,341 | 39.3 K to 38.3 K (-2.55 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 113.81 | 401 | 45,639 | 39,343 | 39.7 K to 39.3 K (-1.01 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 113.02 | 727 | 82,168 | 39,744 | 40.5 K to 39.7 K (-1.80 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 111.92 | 216 | 24,175 | 40,471 | 40.7 K to 40.5 K (-0.53 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 110.97 | 2,343 | 260,012 | 40,687 | 43 K to 40.7 K (-5.45 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 109.98 | 8,133 | 894,458 | 43,030 | 51.2 K to 43 K (-15.90 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 109.07 | 6,661 | 726,503 | 51,163 | 57.8 K to 51.2 K (-11.52 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 108.20 | 3,739 | 404,549 | 57,824 | 61.6 K to 57.8 K (-6.07 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 107.22 | 276 | 29,593 | 61,563 | 61.8 K to 61.6 K (-0.45 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Payment of Exercise | F | 111.18 | 11,429 | 1,270,676 | 61,839 | 73.3 K to 61.8 K (-15.60 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | D | 111.18 | 1,338 | 148,759 | 73,268 | 74.6 K to 73.3 K (-1.79 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Buy | M | 5.95 | 25,000 | 148,750 | 74,606 | 49.6 K to 74.6 K (+50.40 %) |
| Sep 30 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Buy | M | 5.95 | 25,000 | 148,750 | 49,606 | 24.6 K to 49.6 K (+101.60 %) |
| Sep 29 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | M | 0.00 | 6,546 | 0 | 13,092 | |
| Sep 29 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Payment of Exercise | F | 113.56 | 2,434 | 276,405 | 24,606 | 27 K to 24.6 K (-9.00 %) |
| Sep 29 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Buy | M | 0.00 | 6,546 | 0 | 27,040 | 20.5 K to 27 K (+31.94 %) |
| Aug 26 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 19.08 | 400,000 | 7,632,000 | 400,000 | |
| Jun 29 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Jun 29 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Mar 10 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | M | 0.00 | 6,072 | 0 | 0 | |
| Mar 10 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Payment of Exercise | F | 12.48 | 1,992 | 24,860 | 20,494 | 22.5 K to 20.5 K (-8.86 %) |
| Mar 10 2020 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Buy | M | 0.00 | 6,072 | 0 | 22,486 | 16.4 K to 22.5 K (+36.99 %) |
| Sep 30 2019 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 0.00 | 19,638 | 0 | 100,000 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 0.00 | 19,638 | 0 | 100,000 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Mar 12 2019 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 0.00 | 607,248 | 0 | 607,248 | |
| Dec 14 2018 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 2.30 | 1,970,000 | 4,531,000 | 1,970,000 | |
| Nov 30 2018 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | M | 1.49 | 8,333 | 12,416 | 0 | |
| Nov 30 2018 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Buy | M | 1.49 | 8,333 | 12,416 | 48,333 | 40 K to 48.3 K (+20.83 %) |
| Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 | |
| May 15 2018 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Buy | P | 1.65 | 100,000 | 164,620 | 328,279 | 228.3 K to 328.3 K (+43.81 %) |
| Nov 13 2017 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Buy | P | 1.13 | 100,000 | 113,050 | 228,279 | 128.3 K to 228.3 K (+77.96 %) |
| May 25 2017 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 30,000 | |
| May 11 2017 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Buy | P | 0.84 | 50,000 | 41,980 | 128,279 | 78.3 K to 128.3 K (+63.87 %) |
| Nov 16 2016 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 1.35 | 550,000 | 742,500 | 550,000 | |
| Nov 16 2016 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 1.35 | 550,000 | 742,500 | 550,000 | |
| May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | A | 3.22 | 30,000 | 96,600 | 30,000 | |
| Apr 01 2016 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | M | 1.28 | 201,991 | 258,548 | 500,000 | |
| Apr 01 2016 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | M | 1.28 | 198,009 | 253,452 | 701,991 | |
| Apr 01 2016 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 5.18 | 226,769 | 1,175,616 | 78,279 | 305 K to 78.3 K (-74.34 %) |
| Apr 01 2016 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Buy | M | 1.28 | 201,991 | 258,548 | 305,048 | 103.1 K to 305 K (+196.00 %) |
| Apr 01 2016 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Sell | S | 5.19 | 198,009 | 1,028,003 | 103,057 | 301.1 K to 103.1 K (-65.77 %) |
| Apr 01 2016 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Buy | M | 1.28 | 198,009 | 253,452 | 301,066 | 103.1 K to 301.1 K (+192.14 %) |
| Mar 17 2016 | NVAX | NOVAVAX INC | Erck Stanley C | President and CEO | Option Exercise | A | 4.99 | 900,000 | 4,491,000 | 900,000 | |
| Feb 01 2016 | NVAX | NOVAVAX INC | Erck Stanley C | CEO and President | Buy | P | 4.38 | 2,072 | 9,075 | 103,057 | 101 K to 103.1 K (+2.05 %) |
| Aug 04 2015 | NVAX | NOVAVAX INC | Erck Stanley C | CEO and President | Buy | P | 2.28 | 3,207 | 7,312 | 100,985 | 97.8 K to 101 K (+3.28 %) |
| May 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | A | 11.39 | 15,000 | 170,850 | 15,000 | |
| Mar 09 2015 | NVAX | NOVAVAX INC | Erck Stanley C | CEO and President | Option Exercise | A | 8.94 | 900,000 | 8,046,000 | 900,000 | |
| Jan 04 2008 | IOMI | INTERCELL USA, INC ... | Erck Stanley C | President & CEO | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
| Aug 20 2007 | IOMI | INTERCELL USA, INC ... | Erck Stanley C | President & CEO | Option Exercise | M | 0.91 | 25,000 | 22,750 | 346,076 | |
| Aug 20 2007 | IOMI | INTERCELL USA, INC ... | Erck Stanley C | President & CEO | Buy | M | 0.91 | 25,000 | 22,750 | 25,000 | 0 to 25 K |
| Mar 07 2007 | IOMI | INTERCELL USA, INC ... | Erck Stanley C | President & CEO | Option Exercise | A | 4.95 | 225,000 | 1,113,750 | 1,121,149 | |
| Feb 17 2006 | IOMI | INTERCELL USA, INC ... | Erck Stanley C | President and CEO | Option Exercise | A | 5.51 | 250,000 | 1,377,500 | 896,149 |
Page: 1